Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.16 USD
−77.09 M USD
120.00 K USD
20.64 M
About Fractyl Health, Inc.
Sector
Industry
CEO
Harith Rajagopalan
Website
Headquarters
Burlington
FIGI
BBG002Y7NH72
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GUTS is 2.12 USD — it has increased by 4.57% in the past 24 hours. Watch Fractyl Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fractyl Health, Inc. stocks are traded under the ticker GUTS.
GUTS stock has risen by 15.73% compared to the previous week, the month change is a −12.34% fall, over the last year Fractyl Health, Inc. has showed a −84.58% decrease.
We've gathered analysts' opinions on Fractyl Health, Inc. future price: according to them, GUTS price has a max estimate of 18.00 USD and a min estimate of 13.00 USD. Watch GUTS chart and read a more detailed Fractyl Health, Inc. stock forecast: see what analysts think of Fractyl Health, Inc. and suggest that you do with its stocks.
GUTS reached its all-time high on Feb 2, 2024 with the price of 14.50 USD, and its all-time low was 1.74 USD and was reached on Aug 8, 2024. View more price dynamics on GUTS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GUTS stock is 12.57% volatile and has beta coefficient of 2.99. Track Fractyl Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Fractyl Health, Inc. there?
Today Fractyl Health, Inc. has the market capitalization of 94.75 M, it has increased by 1.05% over the last week.
Yes, you can track Fractyl Health, Inc. financials in yearly and quarterly reports right on TradingView.
Fractyl Health, Inc. is going to release the next earnings report on Apr 7, 2025. Keep track of upcoming events with our Earnings Calendar.
GUTS earnings for the last quarter are −0.43 USD per share, whereas the estimation was −0.50 USD resulting in a 14.00% surprise. The estimated earnings for the next quarter are −0.43 USD per share. See more details about Fractyl Health, Inc. earnings.
GUTS net income for the last quarter is −23.17 M USD, while the quarter before that showed −17.23 M USD of net income which accounts for −34.50% change. Track more Fractyl Health, Inc. financial stats to get the full picture.
No, GUTS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fractyl Health, Inc. EBITDA is −80.81 M USD, and current EBITDA margin is −42.13 K%. See more stats in Fractyl Health, Inc. financial statements.
Like other stocks, GUTS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fractyl Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Fractyl Health, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Fractyl Health, Inc. stock shows the sell signal. See more of Fractyl Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.